Literature DB >> 10996840

Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP)

R Paolini, F Fabris, G Cella.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996840     DOI: 10.1002/1096-8652(200010)65:2<177::aid-ajh17>3.0.co;2-k

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report.

Authors:  Tomohide Hayashi; Naoki Akioka; Daina Kashiwazaki; Naoya Kuwayama; Satoshi Kuroda
Journal:  Childs Nerv Syst       Date:  2015-02-08       Impact factor: 1.475

2.  A case of late stent thrombosis following platelet transfusion in a patient with aplastic anemia.

Authors:  Hyun-Sung Shin; Tae Soo Kang
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

3.  Primary percutaneous coronary intervention for acute myocardial infarction with idiopathic thrombocytopenic purpura: a case report.

Authors:  Jun Hyung Kim; Keon Uk Park; Woo Jung Chun; Seong Ho Kim; Deuk Young Nah
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

4.  Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura.

Authors:  Julide Yagmur; Mehmet Cansel; Nusret Acikgoz; Murat Yagmur; Ferhat Eyupkoca; Necip Ermis; Erdal Akturk
Journal:  Tex Heart Inst J       Date:  2012

Review 5.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561

6.  Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.

Authors:  Omar Chehab; Nadine Abdallah; Amjad Kanj; Mohit Pahuja; Oluwole Adegbala; Rami Z Morsi; Tushar Mishra; Luis Afonso; Aiden Abidov
Journal:  Clin Cardiol       Date:  2019-11-11       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.